World's Best Scientists 2026 revealed!
Claudio Bordignon

Claudio Bordignon

D-Index & Metrics

Immunology

D-Index
82
Citations
29281
World Ranking
1487
National Ranking
58

Medicine

D-Index
82
Citations
29370
World Ranking
15962
National Ranking
627

Claudio Bordignon publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Claudio Bordignon sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 393 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Claudio Bordignon D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Claudio Bordignon sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 82 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Claudio Bordignon is affiliated with MolMed in Italy and conducts research primarily within the field of Medicine, with a focus on Genetics, Neurology, Oncology, Molecular Biology, and Pathology and Forensic Medicine. Their scholarly output includes studies concerning diagnosis and treatment of central nervous system (CNS) lymphomas and gliomas, as well as investigations into CAR-T cell therapy and virus-based gene therapy.

The main topics addressed in their work are:

  • CNS Lymphoma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Virus-based gene therapy research
  • Viral Infectious Diseases and Gene Expression in Insects
  • Lymphoma Diagnosis and Treatment
  • Brain Metastases and Treatment

Bordignon has collaborated frequently with several coauthors, including Andrés J.M. Ferreri, Teresa Calimeri, Maurilio Ponzoni, Flavio Curnis, and Gian Marco Conte. These partnerships have contributed to the advancement of various oncology and immunology topics.

Their publication venues are diverse and include:

  • Frontiers in Immunology
  • Blood Advances
  • SSRN Electronic Journal
  • Molecular Biology Reports
  • Journal of Geriatric Oncology

Among their recent papers are:

  • "CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice," published in Frontiers in Immunology in 2020
  • "Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial," published in Blood Advances in 2020
  • "Blood-Brain Barrier Permeabilization with Engineered Tumor Necrosis Factor-α Followed by R-CHOP Is an Active and Safe Salvage Therapy in Primary CNS Lymphoma," published in SSRN Electronic Journal in 2020
  • "Impact of Ilex paraguariensis extract on osteoblastic phenotype expression," published in Molecular Biology Reports in 2025
  • "Evaluation of treatment strategies for colorectal cancer in older adults: A scoping review of observational studies," published in Journal of Geriatric Oncology in 2025

Claudio Bordignon is recognized as a member of the European Molecular Biology Organization (EMBO), reflecting affiliation with a prominent scientific community in molecular biology.

Best Publications

  • HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia

    Chiara Bonini;Giuliana Ferrari;Simona Verzeletti;Paolo Servida

  • Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning

    Alessandro Aiuti;Shimon Slavin;Memet Aker;Francesca Ficara

  • Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.

    Alessandra Biffi;Eugenio Montini;Laura Lorioli;Martina Cesani

  • Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

    Margherita Norelli;Barbara Camisa;Giulia Barbiera;Laura Falcone

  • Type 1 T regulatory cells.

    Maria Grazia Roncarolo;Rosa Bacchetta;Claudio Bordignon;Satwant Narula

  • Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency

    Alessandro Aiuti;Federica Cattaneo;Stefania Galimberti;Ulrike Benninghoff

  • Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients

    Claudio Bordignon;Luigi D. Notarangelo;Nadia Nobili;Giuliana Ferrari

  • Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs.

    Maurilio Sampaolesi;Stephane Blot;Giuseppe D'antona;Nicolas Granger

  • IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors

    Nicoletta Cieri;Barbara Camisa;Fabienne Cocchiarella;Mattia Forcato

  • Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation

    Luca Vago;Serena Kimi Perna;Monica Zanussi;Benedetta Mazzi

  • Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer

    Elena Provasi;Pietro Genovese;Angelo Lombardo;Zulma Magnani

  • Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

    Fabio Ciceri;Chiara Bonini;Maria Teresa Lupo Stanghellini;Attilio Bondanza

  • Tumor-mediated liver X receptor-[alpha] activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses

    Eduardo J. Villablanca;Laura Raccosta;Dan Zhou;Raffaella Fontana

  • CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma

    Monica Casucci;Benedetta Nicolis di Robilant;Laura Falcone;Barbara Camisa

  • Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells

    Alessandra Biffi;Michele De Palma;Angelo Quattrini;Ubaldo Del Carro

  • Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy

    Alessandro Aiuti;Barbara Cassani;Grazia Andolfi;Massimiliano Mirolo

  • The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies.

    Catia Traversari;Sarah Marktel;Zulma Magnani;Patrizia Mangia

  • Peripheral Blood Lymphocytes as Target Cells of Retroviral Vector-Mediated Gene Transfer

    Fulvio Mavilio;Giuliana Ferrari;Silvano Rossini;Nadia Nobili

  • Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines.

    Rosa Bacchetta;Claudia Sartirana;Megan K. Levings;Claudio Bordignon

  • Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice

    Alessandra Biffi;Alessia Capotondo;Stefania Fasano;Ubaldo del Carro

Frequent Co-Authors

Chiara Bonini
Chiara Bonini Vita-Salute San Raffaele University
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Catia Traversari
Catia Traversari MolMed (Italy)
Luca Vago
Luca Vago Vita-Salute San Raffaele University
Alessandro Aiuti
Alessandro Aiuti Vita-Salute San Raffaele University
Maria Grazia Roncarolo
Maria Grazia Roncarolo Stanford University
Luigi Naldini
Luigi Naldini Vita-Salute San Raffaele University
Maurilio Ponzoni
Maurilio Ponzoni Vita-Salute San Raffaele University
Federico Caligaris-Cappio
Federico Caligaris-Cappio Vita-Salute San Raffaele University
Armando Santoro
Armando Santoro Humanitas University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open up diverse career opportunities. Nursing roles, for instance, are popular entry points into the medical field, offering paths that complement Immunology studies.

If you're exploring options with flexible admissions, you might consider programs categorized as which LPN programs are easiest to get into. Licensed Practical Nurse (LPN) programs provide foundational clinical experience and often serve as stepping stones for further education.

For advanced practice, many students look into the easiest nurse practitioner degree programs. These programs offer streamlined curricula, allowing students to progress efficiently toward becoming nurse practitioners.

Specializing in psychiatric care is another promising direction. You can find information on the best PMHNP programs, which emphasize strong clinical placement opportunities—a crucial factor for practical experience.

Cost is also a major consideration. For those seeking budget-friendly options, the cheapest PMHNP programs provide valuable training without the heavy financial burden.

Exploring these related degrees can enhance your knowledge and skills in Immunology-related fields while providing viable career pathways in healthcare.

Best Scientists Citing Claudio Bordignon

Trending Scientists

Recently Published Articles